Caricamento...
Robust EM Continual Reassessment Method in Oncology Dose Finding
The continual reassessment method (CRM) is a commonly used dose-finding design for phase I clinical trials. Practical applications of this method have been restricted by two limitations: (1) the requirement that the toxicity outcome needs to be observed shortly after the initiation of the treatment;...
Salvato in:
| Autori principali: | , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2011
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3286608/ https://ncbi.nlm.nih.gov/pubmed/22375092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1198/jasa.2011.ap09476 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|